Brachytherapy in cervical cancer

Response and treatment-related complication in High Dose Rate brachytherapy in locally advanced cervical cancer, randomized comparison, weakly versus every other day's (short course) method during one weak in 2022-2023

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200802048273N1

Enrollment

Registered

2022-05-28

Start date

2022-06-22

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer carcinoma. Malignant neoplasm of cervix uteri

Interventions

Intervention 1: Intervention group (brachytherapy during one week): Treatment with high-dose-rate brachytherapy in patients with cervical cancer after implantation of brachytherapy catheters every oth

Eligibility

Sex/Gender

Female

Age

No minimum to 70 Years

Inclusion criteria

Inclusion criteria: Age less than 70 Adenocarcinoma and squamous cell carcinoma histology Good Performance status Stage 1b-4a HB=10

Exclusion criteria

Exclusion criteria: The patient has not done MRI before the treatment initiation Recurrant malignancy patients Patients undergone other treatment options such as surgery

Design outcomes

Primary

Measure	Time frame
Complications of treatment related cystitis based on common terminology criteria for adverse effects. Timepoint: Before starting treatment,One week after treatment,One month after treatment,Three month after treatment,Six month after treatment,One year after treatment. Method of measurement: Complications were assessed by a radiotherapist based on a guide to common terminology criteria for adverse effects.;Complications of treatment-related proctitis based on common terminology criteria for adverse effects. Timepoint: Before starting treatment,One week after treatment,One month after. Method of measurement: Complications were assessed by a radiotherapist based on a guide to common terminology criteria for adverse effects.;Complications of treatment-related vaginitis based on common terminology criteria for adverse effects. Timepoint: Before starting treatment,One week after treatment,One month after. Method of measurement: Complications were assessed by a radiotherapist based on a guide to common terminology criteria for adverse effects.	—

Measure

Time frame

Complications of treatment related cystitis based on common terminology criteria for adverse effects. Timepoint: Before starting treatment,One week after treatment,One month after treatment,Three month after treatment,Six month after treatment,One year after treatment. Method of measurement: Complications were assessed by a radiotherapist based on a guide to common terminology criteria for adverse effects.;Complications of treatment-related proctitis based on common terminology criteria for adverse effects. Timepoint: Before starting treatment,One week after treatment,One month after. Method of measurement: Complications were assessed by a radiotherapist based on a guide to common terminology criteria for adverse effects.;Complications of treatment-related vaginitis based on common terminology criteria for adverse effects. Timepoint: Before starting treatment,One week after treatment,One month after. Method of measurement: Complications were assessed by a radiotherapist based on a guide to common terminology criteria for adverse effects.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Jafari

Tehran University of Medical Sciences

fatemeh.jafari92@yahoo.com+98 21 6119 2585

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026